clinical trial · NCT07377474
A Study to Investigate the Safety and Effectiveness of the Technolas® TENEO 317 Model 2 Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Myopia or Myopic Astigmatism
Myopic AstigmatismTENEO 317 Model 2 (1.28 US) Excimer Laser
brief summary
This will be a multicenter, prospective, open label, non-randomized, single arm study evaluating the safety and effectiveness of the Technolas® TENEO 317 Model 2 (version 1.28 US software) Excimer Laser when used in LASIK surgery to treat myopia or myopic astigmatism. One or both eyes of a subject may be treated so long as both eyes meet all inclusion/exclusion requirements.
started
Apr 1, 2026
primary completion
Sep 1, 2027
completion
Sep 1, 2027
last updated
Jan 30, 2026
official title
A Study to Investigate the Safety and Effectiveness of the Technolas® TENEO 317 Model 2 Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Myopia or Myopic Astigmatism With Sphere Between 0.00D and -1.00D
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol